Modified Turmeric Compound Eases Symptoms Of Major Depressive Disorder

An Australian clinical trial that tested a proprietary curcumin-based supplement on 56 people diagnosed with major depressive disorder found that it worked better than a placebo on reducing self-reported depressive and anxiety symptoms. BCM-95 Curcumin, developed by DolCas Biotech, LLC, worked even better on people with atypical depression, which is generally more difficult to treat. Curcumin is the main curcuminoid derived from the spice turmeric. DolCas Biotech scientists developed a way to process curcumin – which is highly insoluble – to make it much more bioavailable and therefore therapeutically useful.